Analyst Report: Carborundum Universal (CUMI) Capacity Expansion Analysis

1. ராம்ப்-அவேர் கேட்டலிஸ்ட் கணக்கீடு

Carborundum Universal (CUMI) has commenced commercial production at its new Hosur facility, doubling its cutting and grinding wheel capacity from 45 million to 90 million units. * Capex Outlay: ₹83 Crore (funded entirely via internal accruals). * Peak Revenue Potential: ₹160 Crore. * TTM Revenue Context: ₹3,419 Crore. The peak revenue potential represents 4.68% of TTM revenue. * Ramp-up Assumptions: Given that the existing capacity was operating at 86% utilization as of February 2026, demand is strong. However, doubling capacity takes time to absorb. We assume a 2-year ramp-up: * Year 1 (FY27): 30% capacity utilization of the new facility -> ₹48 Crore incremental revenue (1.4% uplift over TTM revenue). * Year 2 (FY28 - Steady State): 100% capacity utilization -> ₹160 Crore incremental revenue (4.68% uplift over TTM revenue). * Margin & EPS Impact: * Operating Profit Margin (OPM) is currently 17.0%. * At steady state, ₹160 Cr revenue at 17% OPM yields ₹27.2 Cr incremental EBITDA. * Applying depreciation on ₹83 Cr capex (assume 10% straight-line = ₹8.3 Cr) and a 25% tax rate, the incremental PAT is approximately ₹14.17 Crore. * This translates to an incremental EPS of ₹0.66 (on ~21.3 Cr shares), representing a 5.2% uplift over TTM EPS of ₹12.71.

2. தொழில்துறை மூலதனத் தீவிரம் & வளர்ச்சித் தன்மை

• Capital Intensity: Medium. Abrasives manufacturing requires specialized machinery and kilns but is not as capital-heavy as primary metals or cement.
• Industry CAGR: The abrasives and industrial ceramics market is mature, growing structurally at 4-5% annually, closely tracking industrial production and fabrication activity.
• Execution Difficulty: Moderate. CUMI has deep manufacturing experience and has integrated German technology (DRONCO GmbH) for this plant, minimizing execution risk.

3. மல்டிபேக்கர் தர மதிப்பீடு

• Financial Health: Excellent balance sheet with zero debt (D/E of 0.00) and a healthy ROCE of 18.0%.
• Earnings Momentum: Poor. Despite the strong balance sheet, CUMI is facing severe earnings deceleration. TTM PAT of ₹271 Cr is down significantly from FY24 levels. Quarterly EPS has declined from ₹7.09 in Mar 2024 to ₹3.99 in Dec 2025.
• Headwinds: The primary drag is geopolitical. US SDN sanctions on Russian subsidiary VAW have blocked USD/Euro payments, causing a 25% volume reduction and a ₹104.1 Cr impairment. Additionally, cheap Chinese imports are hurting realizations in the Electro Minerals segment.

4. மதிப்பீடு & சூழ்நிலைகள்

• Current Valuation: At ₹758.5, CUMI trades at a trailing P/E of 59.7x, which is a premium to its peer median (Grindwell, Wendt) of 49.4x. This high multiple leaves little room for valuation expansion, especially during an earnings down-cycle.
• Base Case (15% Upside): Domestic growth and the Hosur expansion offset some international pain. P/E contracts slightly to 50x on stabilized EPS of ₹17.50 over 24 months, leading to a target price of ~₹875.
• Bull Case (30% Upside): Sanctions on VAW are resolved or bypassed, European acquisitions (Rhodius/Awuko) turn highly profitable, and Hosur ramps up rapidly. EPS reaches ₹20.00, valued at 50x P/E -> Target ₹1,000.
• Bear Case (-20% Downside): Further impairments in Russia, worsening Chinese dumping, and slow domestic recovery drag EPS down to ₹11.00. P/E de-rates to 45x -> Target ₹495.

5. தீர்ப்பின் காரணம்

While the Hosur capacity doubling is a positive organic step funded cleanly through internal accruals, its overall size (₹160 Cr peak revenue) is too small (~4.7% of TTM revenue) to move the needle for a ₹16,147 Cr market cap company. The stock's high valuation (59.7x P/E) combined with severe geopolitical headwinds in Russia and margin pressure from Chinese imports makes a multibagger outcome highly unlikely in the medium term.